Polyaspartate-derived synthetic antimicrobial polymer enhances the activity of rifampicin against multidrug-resistant Pseudomonas aeruginosa infections

Infections caused by multidrug-resistant Pseudomonas aeruginosa ( P. aeruginosa ) pose major challenges for treatment due to the acquired, adaptive, and intrinsic resistance developed by the bacteria.